The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sanders Corazon (corsee) D. since 2023.
This trader's CIK number is 1796536.
At the time of last reporting, Sanders Corazon (corsee) D. was the Director of Beone Medicines Ltd.. (stock ticker symbol ONC).
Also see all insider trading activities at Beone Medicines Ltd..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ONC | 0 | $0 | 5,292 | $1,794,797 | 5,292 | $832,658 |
| 2023 | ONC | 0 | $0 | 578 | $105,020 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RARE | 0 | $0 | 2,405 | $89,922 | 0 | $0 |
| 2024 | RARE | 0 | $0 | 584 | $23,932 | 0 | $0 |
| 2023 | RARE | 0 | $0 | 2,070 | $104,054 | 0 | $0 |
2. Ultragenyx Pharmaceutical Inc. (RARE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-11-26 | ONC | Sale | 2,627 | 341.34 | 896,692 |
| 2025-11-26 | ONC | Option Ex | 2,627 | 159.03 | 417,771 |
| 2025-09-05 | ONC | Sale | 2,665 | 337.00 | 898,105 |
| 2025-09-05 | ONC | Option Ex | 2,665 | 155.68 | 414,887 |
| 2023-06-23 | BGNE | Sale | 578 | 181.70 | 105,020 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-20 | RARE | Sale | 2,405 | 37.39 | 89,922 |
| 2024-07-02 | RARE | Sale | 584 | 40.98 | 23,932 |
| 2023-06-30 | RARE | Sale | 585 | 46.76 | 27,354 |
| 2023-06-08 | RARE | Sale | 1,485 | 51.65 | 76,700 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sanders Corazon (corsee) D. (Director of Beone Medicines Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.